Efficacy and Safety of ICIs Plus Chemotherapy as First-Line Treatment for Extensive-Stage SCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and safety of first-line immune checkpoint inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: A network meta-analysis
Lung Cancer 2023 Feb 04;[EPub Ahead of Print], S Wang, Y Li, Z Liu, W Tian, Y Zeng, J Liu, S Zhang, Y Peng, F WuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.